Use of GLP‐1 receptor agonists and subsequent risk of alcohol‐related events. A nationwide register‐based cohort and self‐controlled case series study

Animal studies have related glucagon‐like peptide 1 receptor agonists (GLP‐1) to lower alcohol intake. We examined whether GLP‐1 was associated with risk of alcohol‐related events in a nationwide cohort study and a self‐controlled case series analysis including all new users of GLP1 (n = 38 454) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wium‐Andersen, Ida Kim, Wium‐Andersen, Marie Kim, Fink‐Jensen, Anders, Rungby, Jørgen, Jørgensen, Martin Balslev, Osler, Merete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804689/
https://www.ncbi.nlm.nih.gov/pubmed/35968738
http://dx.doi.org/10.1111/bcpt.13776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804689/
https://www.ncbi.nlm.nih.gov/pubmed/35968738
http://dx.doi.org/10.1111/bcpt.13776

Ejemplares similares